MOLOGEN AG: Combination data of TLR9 agonist lefitolimod with checkpoint inhibitors in preclinical tumor models
Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)
Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics
MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes
Haplogen's Novel Antiviral Target Partnered with Evotec Published in 'Nature'
Evotec and Eternygen to Develop Novel Metabolic Disease Therapy
Evotec to Attend Three Upcoming Investor Conferences
GFT Spotlights 2017 Trends Shaping Financial Services